{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T01:50:25Z","timestamp":1780710625685,"version":"3.54.1"},"reference-count":26,"publisher":"Pharmaceutical Society of Japan","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biological &amp; Pharmaceutical Bulletin","Biol. Pharm. Bull."],"published-print":{"date-parts":[[2023,10,1]]},"DOI":"10.1248\/bpb.b23-00188","type":"journal-article","created":{"date-parts":[[2023,9,30]],"date-time":"2023-09-30T22:56:05Z","timestamp":1696114565000},"page":"1479-1483","source":"Crossref","is-referenced-by-count":5,"title":["Preparation and Evaluation of Paclitaxel-Loaded PEGylated Niosomes Composed of Sorbitan Esters"],"prefix":"10.1248","volume":"46","author":[{"given":"Mika","family":"Hosokawa","sequence":"first","affiliation":[{"name":"Laboratory of Pharmaceutics, Kobe Pharmaceutical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiori","family":"Ito","sequence":"additional","affiliation":[{"name":"Laboratory of Pharmaceutics, Kobe Pharmaceutical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaito","family":"Noda","sequence":"additional","affiliation":[{"name":"Laboratory of Pharmaceutics, Kobe Pharmaceutical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Kono","sequence":"additional","affiliation":[{"name":"Laboratory of Pharmaceutics, Kobe Pharmaceutical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken-ichi","family":"Ogawara","sequence":"additional","affiliation":[{"name":"Laboratory of Pharmaceutics, Kobe Pharmaceutical University"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"163","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Mahale NB, Thakkar PD, Mali RG, Walunj DR, Chaudhari SR. Niosomes: novel sustained release nonionic stable vesicular systems\u2014an overview. <i>Adv. Colloid Interface Sci.<\/i>, <b>183-184<\/b>, 46\u201354 (2012).","DOI":"10.1016\/j.cis.2012.08.002"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Goldspiel BR. Clinical overview of the taxanes. <i>Pharmacotherapy<\/i>, <b>17<\/b>, 110S\u2013125S (1997).","DOI":"10.1002\/j.1875-9114.1997.tb03813.x"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Mikuni K, Nakanishi K, Hara K, Hara K, Iwatani W, Amano T, Nakamura K, Tsuchiya Y, Okumoto H, Mandai T. <i>In vivo<\/i> antitumor activity of novel water-soluble taxoids. <i>Biol. Pharm. Bull.<\/i>, <b>31<\/b>, 1155\u20131158 (2008).","DOI":"10.1248\/bpb.31.1155"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Weiss RB, Donehower RC, Wiernik PH, Ohnuma T, Gralla RJ, Trump DL, Baker JR Jr, Van Echo DA, Von Hoff DD, Leyland-Jones B. Hypersensitivity reactions from taxol. <i>J. Clin. Oncol.<\/i>, <b>8<\/b>, 1263\u20131268 (1990).","DOI":"10.1200\/JCO.1990.8.7.1263"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Stage TB, Bergmann TK, Kroetz DL. Clinical pharmacokinetics of paclitaxel monotherapy: an updated literature review. <i>Clin. Pharmacokinet.<\/i>, <b>57<\/b>, 7\u201319 (2018).","DOI":"10.1007\/s40262-017-0563-z"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Yamada K. Clinical development of abraxane, albumin-bound paclitaxel. <i>Drug Deliv. Syst.<\/i>, <b>24<\/b>, 38\u201344 (2009).","DOI":"10.2745\/dds.24.38"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Yoshizawa Y, Kono Y, Ogawara KI, Kimura T, Higaki K. PEG liposomalization of paclitaxel improved its <i>in vivo<\/i> disposition and anti-tumor efficacy. <i>Int. J. Pharm.<\/i>, <b>142<\/b>, 132\u2013141 (2011).","DOI":"10.1016\/j.ijpharm.2011.04.008"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Ishida T, Ichihara M, Wang X, Yamamoto K, Kimura J, Majima E, Kiwada H. Injection of PEGylated liposomes in rats elicits PEG-specific IgM, which is responsible for rapid elimination of a second dose of PEGylated liposomes. <i>J. Control. Release<\/i>, <b>112<\/b>, 15\u201325 (2006).","DOI":"10.1016\/j.jconrel.2006.01.005"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Maeda H, Wu J, Sawa T, Matsumura Y, Hori K. Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. <i>J. Control. Release<\/i>, <b>65<\/b>, 271\u2013284 (2000).","DOI":"10.1016\/S0168-3659(99)00248-5"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Ogawara K, Yoshizawa Y, Un K, Araki T, Kimura T, Higaki K. Nanoparticle-based passive drug targeting to tumors: considerations and implications for optimization. <i>Biol. Pharm. Bull.<\/i>, <b>36<\/b>, 698\u2013702 (2013).","DOI":"10.1248\/bpb.b13-00015"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Araki T, Kono Y, Ogawara K, Watanabe T, Ono T, Kimura T, Higaki K. Formulation and evaluation of paclitaxel-loaded polymeric nanoparticles composed of polyethylene glycol and polylactic acid block copolymer. <i>Biol. Pharm. Bull.<\/i>, <b>35<\/b>, 1306\u20131313 (2012).","DOI":"10.1248\/bpb.b12-0020"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Ogawara KI, Higaki K. Nanoparticle-based photodynamic therapy: current status and future application to improve outcomes of cancer treatment. <i>Chem. Pharm. Bull.<\/i>, <b>65<\/b>, 637\u2013641 (2017).","DOI":"10.1248\/cpb.c17-00063"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Oku N. Innovations in liposomal DDS technology and its application for the treatment of various diseases. <i>Biol. Pharm. Bull.<\/i>, <b>40<\/b>, 119\u2013127 (2017).","DOI":"10.1248\/bpb.b16-00857"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Asai T. Nanoparticle-mediated delivery of anticancer agents to tumor angiogenic vessels. <i>Biol. Pharm. Bull.<\/i>, <b>35<\/b>, 1855\u20131861 (2012).","DOI":"10.1248\/bpb.b212013"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Pourmoghadasiyan B, Tavakkoli F, Beram FM, Badmasti F, Mirzaie A, Kazempour R, Rahimi S, Larijani SF, Hejabi F, Sedaghatnia K. Nanosized paclitaxel-loaded niosomes: formulation, <i>in vitro<\/i> cytotoxicity, and apoptosis gene expression in breast cancer cell lines. <i>Mol. Biol. Rep.<\/i>, <b>49<\/b>, 3597\u20133608 (2022).","DOI":"10.1007\/s11033-022-07199-2"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Zarei M, Norouzian D, Honarvar B, Mohammadi M, Shamabadi HE, Akbarzadeh A. Paclitaxel loaded niosome nanoparticle formulation prepared <i>via<\/i> reverse phase evaporation method: an <i>in vitro<\/i> evaluation. <i>Pak. J. Biol. Sci.<\/i>, <b>16<\/b>, 295\u2013298 (2013).","DOI":"10.3923\/pjbs.2013.295.298"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Sezgin-Bayindir Z, Onay-Besikci A, Vural N, Yuksel N. Niosomes encapsulating paclitaxel for oral bioavailability enhancement: preparation, characterization, pharmacokinetics and biodistribution. <i>J. Microencapsul.<\/i>, <b>30<\/b>, 796\u2013804 (2013).","DOI":"10.3109\/02652048.2013.788088"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Munekane M, Kosugi A, Yamasaki M, Watanabe Y, Kannaka K, Sano K, Yamasaki T, Ogawara KI, Mukai T. Biodistribution study of indium-111-labeled PEGylated niosomes as novel drug carriers for tumor-targeting. <i>J. Drug.<\/i> <i>Deliv. Sci. Technol.<\/i>, <b>75<\/b>, 103648 (2022).","DOI":"10.1016\/j.jddst.2022.103648"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Maruyama M, Tojo H, Toi K, Ienaka Y, Hyodo K, Kikuchi H, Ogawara KI, Higaki K. Effect of doxorubicin release rate from polyethylene glycol-modified liposome on anti-tumor activity in B16-BL6 tumor-bearing mice. <i>J. Pharm. Sci.<\/i>, <b>111<\/b>, 293\u2013297 (2022).","DOI":"10.1016\/j.xphs.2021.11.020"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Shehata T, Kimura T, Higaki K, Ogawara K. <i>In-vivo<\/i> disposition characteristics of PEG niosome and its interaction with serum proteins. <i>Int. J. Pharm.<\/i>, <b>512<\/b>, 322\u2013328 (2016).","DOI":"10.1016\/j.ijpharm.2016.08.058"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Ogawara KI, Fukuoka Y, Yoshizawa Y, Kimura T, Higaki K. Development of safe and potent oil-in-water emulsion of paclitaxel to treat peritoneal dissemination. <i>J. Pharm. Sci.<\/i>, <b>106<\/b>, 1143\u20131148 (2017).","DOI":"10.1016\/j.xphs.2016.12.029"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Ogawara KI, Un K, Minato K, Tanaka KI, Higaki K, Kimura T. Determinants for <i>in vivo<\/i> anti-tumor effects of PEG liposomal doxorubicin: importance of vascular permeability within tumors. <i>Int. J. Pharm.<\/i>, <b>359<\/b>, 234\u2013240 (2008).","DOI":"10.1016\/j.ijpharm.2008.03.025"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Balasubramanian SV, Straubinger RM. Taxol-lipid interactions: taxol-dependent effects on the physical properties of model membranes. <i>Biochemistry<\/i>, <b>33<\/b>, 8941\u20138947 (1994).","DOI":"10.1021\/bi00196a011"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Al-Ahmady ZS, Hadjidemetriou M, Gubbins J, Kostarelos K. Formation of protein corona <i>in vivo<\/i> affects drug release from temperature-sensitive liposomes. <i>J. Control. Release<\/i>, <b>276<\/b>, 157\u2013167 (2018).","DOI":"10.1016\/j.jconrel.2018.02.038"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Haroon HB, Hunter AC, Farhangrazi ZS, Moghimi SM. A brief history of long circulating nanoparticles. <i>Adv. Drug Deliv. Rev.<\/i>, <b>188<\/b>, 114396 (2022).","DOI":"10.1016\/j.addr.2022.114396"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Crielaard BJ, Yousefi A, Schillemans JP, Vermehren C, Buyens K, Braeckmans K, Lammers T, Storm G. An <i>in vitro<\/i> assay based on surface plasmon resonance to predict the <i>in vivo<\/i> circulation kinetics of liposomes. <i>J. Control. Release<\/i>, <b>156<\/b>, 307\u2013314 (2011).","DOI":"10.1016\/j.jconrel.2011.07.023"}],"container-title":["Biological and Pharmaceutical Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/46\/10\/46_b23-00188\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,23]],"date-time":"2023-12-23T04:18:14Z","timestamp":1703305094000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/46\/10\/46_b23-00188\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,1]]},"references-count":26,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1248\/bpb.b23-00188","relation":{},"ISSN":["0918-6158","1347-5215"],"issn-type":[{"value":"0918-6158","type":"print"},{"value":"1347-5215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,1]]},"article-number":"b23-00188"}}